Citigroup Inc Harvard Bioscience Inc Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Citigroup Inc holds 30,036 shares of HBIO stock, worth $64,277. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,036

Previous 9,541 214.81%

Holding current value

$64,277

Previous $27,000 196.3%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$2.64 - $3.54 $54,106 - $72,552	20,495 Added 214.81%	30,036 $80,000
Q2 2024 Aug 12, 2024	BUY	$2.77 - $4.63 $5,523 - $9,232	1,994 Added 26.42%	9,541 $27,000
Q1 2024 May 10, 2024	BUY	$4.02 - $5.39 $4,466 - $5,988	1,111 Added 17.26%	7,547 $31,000
Q4 2023 Feb 09, 2024	BUY	$4.0 - $5.49 $24,876 - $34,142	6,219 Added 2865.9%	6,436 $34,000
Q3 2023 Nov 09, 2023	SELL	$4.0 - $5.82 $45,728 - $66,534	-11,432 Reduced 98.14%	217 $0
Q2 2023 Aug 10, 2023	BUY	$4.19 - $6.16 $48,809 - $71,757	11,649 New	11,649 $63,000
Q3 2022 Nov 10, 2022	SELL	$2.33 - $3.92 $1,244 - $2,093	-534 Reduced 51.95%	494 $1,000
Q2 2022 Aug 10, 2022	SELL	$3.28 - $6.42 $4,300 - $8,416	-1,311 Reduced 56.05%	1,028 $4,000
Q1 2022 May 12, 2022	SELL	$5.16 - $7.14 $46,512 - $64,359	-9,014 Reduced 79.4%	2,339 $15,000
Q4 2021 Feb 10, 2022	BUY	$6.37 - $8.18 $43,577 - $55,959	6,841 Added 151.62%	11,353 $80,000
Q3 2021 Nov 10, 2021	BUY	$6.98 - $8.47 $31,493 - $38,216	4,512 New	4,512 $31,000

Others Institutions Holding HBIO

# of Institutions

Shares Held

30.6M

Call Options Held

700

Put Options Held

2.1K

View Full List

About HARVARD BIOSCIENCE INC

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

More about HBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account